Lipids in Health and Disease, 1476-511X
Journal
1 - 10 out of 22Page size: 10
- 2020
Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study
Eva O. Melin, Jonatan Dereke & Magnus Hillman, 2020, In : Lipids in Health and Disease. 19, 1, 223.Research output: Contribution to journal › Article
Magnitude of rise in proneurotensin is related to amount of triglyceride appearance in blood after standardized oral intake of both saturated and unsaturated fat
Ayesha Fawad, Celine Fernandez, Andreas Bergmann, Joachim Struck, Peter M. Nilsson, Louise Bennet, Marju Orho-Melander & Olle Melander, 2020, In : Lipids in Health and Disease. 19, 1, 191.Research output: Contribution to journal › Article
- 2019
Lower HDL-cholesterol, a known marker of cardiovascular risk, was associated with depression in type 1 diabetes: A cross sectional study
Eva Olga Melin, Hans Olav Thulesius, Magnus Hillman, Ralph Svensson, Mona Landin-Olsson & Maria Thunander, 2019 Mar 18, In : Lipids in Health and Disease. 18, 1, 65.Research output: Contribution to journal › Article
- 2018
Increased apolipoprotein M induced by lack of scavenger receptor BI is not activated via HDL-mediated cholesterol uptake in hepatocytes
Yue Hua Feng, Lu Zheng, Jiang Wei, Miao Mei Yu, Jun Zhang, Guang Hua Luo & Ning Xu, 2018 Aug 25, In : Lipids in Health and Disease. 17, 1, 200.Research output: Contribution to journal › Article
- 2017
17β-estradiol regulates the expression of apolipoprotein M through estrogen receptor α-specific binding motif in its promoter
Jiang Wei, Yang Yu, Guang-Hua Luo, Yue hua Feng, Yuan-ping Shi, Jun Zhang, Qin feng Mu, Miao mei Yu, Li li Pan, Maria Berggren-Söderlund, Peter Nilsson-Ehle, Xiao-Ying Zhang & Ning Xu, 2017 Mar 31, In : Lipids in Health and Disease. 16, 1, p. 1-8 66.Research output: Contribution to journal › Article
HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium
Mario Ruiz Garcia, Hiromi Okada & Björn Dahlbäck, 2017 Feb 8, In : Lipids in Health and Disease. 16, 1, 36.Research output: Contribution to journal › Article
- 2015
Hyperglycemia-induced downregulation of apolipoprotein M expression is not via the hexosamine pathway.
Bo Jiang, Xiaoying Zhang, Dongmei Di, Guanghua Luo, Yuanping Shi, Jun Zhang, Maria Berggren Söderlund, Peter Nilsson-Ehle & Ning Xu, 2015, In : Lipids in Health and Disease. 14, 1, 110.Research output: Contribution to journal › Article
Mevalonate inhibits acid sphingomyelinase activity, increases sphingomyelin levels and inhibits cell proliferation of HepG2 and Caco-2 cells.
Ying Chen, Shu-Chang Xu & Rui-Dong Duan, 2015, In : Lipids in Health and Disease. 14, 130.Research output: Contribution to journal › Article
- 2011
Effects of simvastatin on apolipoprotein M in vivo and in vitro.
Xiaoying Zhang, Shubing Mao, Guanghua Luo, Jiang Wei, Maria Berggren Söderlund, Peter Nilsson-Ehle & Ning Xu, 2011, In : Lipids in Health and Disease. 10, 112.Research output: Contribution to journal › Article
Postprandial lipid responses to an alpha-linolenic acid-rich oil, olive oil and butter in women: A randomized crossover trial
Julia Svensson, Anna Rosenquist & Lena Ohlsson, 2011, In : Lipids in Health and Disease. 10Research output: Contribution to journal › Article